Skip to content

Clinical trials

Completed Observational Triple Negative Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Phase: Observational Status: Completed Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20103
20111
20131
20141
20172
20181
20191
20201
20214
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Case Comprehensive Cancer Center1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Gangnam Severance Hospital1
Hackensack Meridian Health1
Hellenic Cooperative Oncology Group1
Hoffmann-La Roche1
Icahn School of Medicine at Mount Sinai1
Indiana University1
Institut Claudius Regaud1
Instituto Nacional de Cancer, Brazil1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms19
Breast Neoplasms6
Carcinoma, Hepatocellular1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Carcinoma, Transitional Cell1
Colonic Neoplasms1
Endometrial Neoplasms1
Lung Neoplasms1
Melanoma1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.